Investigating how natural antisense RNA affects Alzheimer's disease

THE HUMAN BRAINOME III: EQTL REGULATION BY NATURAL ANTISENSE RNA IN ALZHEIMER S DISEASE

NIH-funded research University of Miami School of Medicine · NIH-10870083

This study is looking at how certain genes might play a role in late-onset Alzheimer's disease by examining a special type of RNA in brain samples, with the hope of finding new ways to help treat the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine NIH-funded
Lab location1 site (Coral Gables, United States)
Project IDNIH-10870083 on NIH RePORTER

What this research studies

This research explores the genetic factors contributing to late-onset Alzheimer's disease by examining how natural antisense RNA influences gene expression and protein production. Using advanced sequencing technology, the study will analyze RNA from brain samples to identify key genetic variations and their effects on disease pathways. By mapping these relationships, the research aims to uncover new insights into the mechanisms of Alzheimer's and potentially identify targets for therapeutic intervention.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with late-onset Alzheimer's disease or those at risk due to genetic factors.

Not a fit: Patients with early-onset Alzheimer's disease or those without a genetic predisposition to late-onset Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for diagnosing or treating Alzheimer's disease.

How similar studies have performed: Previous research using similar genomic and transcriptomic approaches has shown promise in understanding complex diseases, suggesting potential for success in this study.

Where this research is happening

Coral Gables, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's Disease Pathway
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.